Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05568225 |
|---|---|
| Brief Title: | A Study of Etavopivat for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS) |
| First Submitted : | September 15, 2022 |
| First Submitted that Met QC Criteria : | September 30, 2022 |
| First Posted : | October 5, 2022 |
| Last Update Submitted that Met QC Criteria : | April 9, 2024 |
| Last Update Posted : | April 10, 2024 |